Literature DB >> 2897909

The endocrinology of anorexia nervosa and bulimia nervosa.

M M Newman1, K A Halmi.   

Abstract

Considerable evidence exists of hypothalamic dysfunction in patients with anorexia nervosa and bulimia nervosa. This dysfunction is reflected in disturbances of endocrine function including abnormalities of gonadotropin, growth hormone, and corticotropin-releasing hormone secretion. Whereas these disturbances are generally reversed with nutritional rehabilitation and weight restoration, it is not evident to what extent nutritional factors are the primary etiology or whether they unmask an otherwise existing but compensated central disturbance. Similarly, endocrine disturbances may be a final common pathway in which disturbances of diet, weight, activity, stress, and mood as well as hypothalamic dysfunction are expressed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897909

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  6 in total

1.  Recovery of menstrual cycle after therapy for anorexia nervosa.

Authors:  F J Tinahones; B Martínez-Alfaro; M Gonzalo-Marín; J M García-Almeida; L Garrido-Sánchez; F Cardona
Journal:  Eat Weight Disord       Date:  2005-09       Impact factor: 4.652

Review 2.  Hypoglycaemia and anorexia nervosa.

Authors:  D Mattingly; S Bhanji
Journal:  J R Soc Med       Date:  1995-04       Impact factor: 5.344

Review 3.  Nutritional interventions for individuals with bulimia nervosa.

Authors:  S J Salvy; L McCargar
Journal:  Eat Weight Disord       Date:  2002-12       Impact factor: 4.652

4.  The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa.

Authors:  F Lanfranco; L Gianotti; A Picu; S Fassino; G Abbate Daga; V Mondelli; R Giordano; S Grottoli; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 5.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

6.  Anorexia nervosa associated with acromegaloid features, onset of acrocyanosis and Raynaud's phenomenon and worsening of chilblains.

Authors:  M H Rustin; J C Foreman; P M Dowd
Journal:  J R Soc Med       Date:  1990-08       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.